| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 5660 | 2021 |
| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries AP Ambrosy, GC Fonarow, J Butler, O Chioncel, SJ Greene, ... Journal of the American College of Cardiology 63 (12), 1123-1133, 2014 | 2110 | 2014 |
| Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 1903 | 2021 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 1476 | 2019 |
| Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study CSP Lam, VL Roger, RJ Rodeheffer, BA Borlaug, FT Enders, MM Redfield Journal of the American College of Cardiology 53 (13), 1119-1126, 2009 | 1114 | 2009 |
| How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the … B Pieske, C Tschöpe, RA De Boer, AG Fraser, SD Anker, E Donal, ... European heart journal 40 (40), 3297-3317, 2019 | 1085 | 2019 |
| Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction BA Borlaug, RA Nishimura, P Sorajja, CSP Lam, MM Redfield Circulation: Heart Failure 3 (5), 588-595, 2010 | 1026 | 2010 |
| Epidemiology and clinical course of heart failure with preserved ejection fraction CSP Lam, E Donal, E Kraigher‐Krainer, RS Vasan European journal of heart failure 13 (1), 18-28, 2011 | 896 | 2011 |
| Vericiguat in patients with heart failure and reduced ejection fraction PW Armstrong, B Pieske, KJ Anstrom, J Ezekowitz, AF Hernandez, ... New England Journal of Medicine 382 (20), 1883-1893, 2020 | 814 | 2020 |
| Cardiac structure and ventricular–vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota CSP Lam, VL Roger, RJ Rodeheffer, F Bursi, BA Borlaug, SR Ommen, ... Circulation 115 (15), 1982-1990, 2007 | 802* | 2007 |
| Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction BA Borlaug, TP Olson, CSP Lam, KS Flood, A Lerman, BD Johnson, ... Journal of the American College of Cardiology 56 (11), 845-854, 2010 | 765 | 2010 |
| Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 690 | 2021 |
| Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction RJ Mentz, JP Kelly, TG von Lueder, AA Voors, CSP Lam, MR Cowie, ... Journal of the American College of Cardiology 64 (21), 2281-2293, 2014 | 551 | 2014 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 532 | 2022 |
| Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction BA Borlaug, CSP Lam, VL Roger, RJ Rodeheffer, MM Redfield Journal of the American College of Cardiology 54 (5), 410-418, 2009 | 482 | 2009 |
| Age-associated increases in pulmonary artery systolic pressure in the general population CSP Lam, BA Borlaug, GC Kane, FT Enders, RJ Rodeheffer, MM Redfield Circulation 119 (20), 2663-2670, 2009 | 468 | 2009 |
| Developing therapies for heart failure with preserved ejection fraction: current state and future directions J Butler, GC Fonarow, MR Zile, CS Lam, L Roessig, EB Schelbert, ... JACC: Heart Failure 2 (2), 97-112, 2014 | 431 | 2014 |
| Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ... Journal of the American College of Cardiology 71 (23), 2628-2639, 2018 | 426 | 2018 |
| The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 B Vogel, M Acevedo, Y Appelman, CNB Merz, A Chieffo, GA Figtree, ... The Lancet 397 (10292), 2385-2438, 2021 | 409 | 2021 |
| Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management MD Cappellini, J Comin‐Colet, A de Francisco, A Dignass, W Doehner, ... American journal of hematology 92 (10), 1068-1078, 2017 | 409 | 2017 |
